湖南方盛制药股份有限公司关于控股股东部分股份解除质押的公告

Core Viewpoint - Hunan Fangsheng Pharmaceutical Co., Ltd. announced that its controlling shareholder, Zhang Qinghua, has completed the release of 14 million shares from pledge, representing 3.19% of the company's total share capital [2]. Group 1: Shareholding and Pledge Details - Zhang Qinghua directly holds a total of 156,019,500 shares, accounting for 35.53% of the company's total shares (439,081,360 shares) [2]. - The total number of shares pledged by Zhang Qinghua is 55,325,200, which represents 35.46% of his directly held shares and 12.60% of the company's total shares [2]. - The subsidiary of Zhang Qinghua's investment company, Taizhou Gengsheng Consulting Co., Ltd., holds 9,131,807 shares, with no shares pledged [2]. - Zhang Zhurong holds 423,300 shares, with no shares pledged [2]. - In total, Zhang Qinghua and his concerted parties hold 165,574,607 shares, with a total of 55,325,200 shares pledged, which is 33.41% of their total holdings [2]. Group 2: Future Plans and Compliance - There are currently no plans for further equity pledge financing following the release of the pledged shares [3]. - The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations if any equity pledge financing occurs in the future [3].